E.A. van Schaick

678 total citations
17 papers, 575 citations indexed

About

E.A. van Schaick is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, E.A. van Schaick has authored 17 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Physiology and 5 papers in Organic Chemistry. Recurrent topics in E.A. van Schaick's work include Adenosine and Purinergic Signaling (13 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Receptor Mechanisms and Signaling (7 papers). E.A. van Schaick is often cited by papers focused on Adenosine and Purinergic Signaling (13 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Receptor Mechanisms and Signaling (7 papers). E.A. van Schaick collaborates with scholars based in Netherlands, United States and Switzerland. E.A. van Schaick's co-authors include Meindert Danhof, Adriaan P. IJzerman, Ron A. A. Mathôt, Ronald Gieschke, Pascal Girard, P. Krishna Pillai, Philippe Jacqmin, Eric Snoeck, Jean‐Louis Steimer and Piet H. van der Graaf and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

E.A. van Schaick

17 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.A. van Schaick Netherlands 13 246 192 96 74 54 17 575
Muhammad Rafehi Germany 15 280 1.1× 218 1.1× 114 1.2× 95 1.3× 21 0.4× 29 536
Gamini Chandrasena United States 17 260 1.1× 42 0.2× 128 1.3× 64 0.9× 75 1.4× 32 577
Aliaa Abdelrahman Germany 21 442 1.8× 657 3.4× 108 1.1× 90 1.2× 16 0.3× 38 1.0k
Duncan Armstrong United Kingdom 13 279 1.1× 45 0.2× 141 1.5× 31 0.4× 41 0.8× 20 744
Anthony H. Ingall United Kingdom 12 240 1.0× 356 1.9× 74 0.8× 37 0.5× 13 0.2× 14 789
M. Ohno Japan 14 411 1.7× 296 1.5× 74 0.8× 27 0.4× 22 0.4× 34 734
Markus Muehlbacher Germany 7 445 1.8× 69 0.4× 30 0.3× 49 0.7× 23 0.4× 8 684
Nicola Giacchè Italy 13 283 1.2× 90 0.5× 23 0.2× 140 1.9× 10 0.2× 22 719
Jun Yuan China 14 336 1.4× 58 0.3× 79 0.8× 32 0.4× 42 0.8× 28 654
Mark Niosi United States 13 172 0.7× 48 0.3× 33 0.3× 238 3.2× 209 3.9× 22 542

Countries citing papers authored by E.A. van Schaick

Since Specialization
Citations

This map shows the geographic impact of E.A. van Schaick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.A. van Schaick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.A. van Schaick more than expected).

Fields of papers citing papers by E.A. van Schaick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.A. van Schaick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.A. van Schaick. The network helps show where E.A. van Schaick may publish in the future.

Co-authorship network of co-authors of E.A. van Schaick

This figure shows the co-authorship network connecting the top 25 collaborators of E.A. van Schaick. A scholar is included among the top collaborators of E.A. van Schaick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.A. van Schaick. E.A. van Schaick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jacqmin, Philippe, Eric Snoeck, E.A. van Schaick, et al.. (2006). Modelling Response Time Profiles in the Absence of Drug Concentrations: Definition and Performance Evaluation of the K–PD Model. Journal of Pharmacokinetics and Pharmacodynamics. 34(1). 57–85. 141 indexed citations
2.
Schaick, E.A. van, Philippe Lechat, Bart Remmerie, et al.. (2003). Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers. Clinical Therapeutics. 25(6). 1687–1699. 37 indexed citations
3.
Schaick, E.A. van, et al.. (1999). Multivariate Quantitative Structure–Pharmacokinetic Relationships (QSPKR) Analysis of Adenosine A1 Receptor Agonists in rat. Journal of Pharmaceutical Sciences. 88(3). 306–312. 32 indexed citations
4.
Graaf, Piet H. van der, et al.. (1999). Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling of Antilipolytic Effects of Adenosine A1 Receptor Agonists in Rats: Prediction of Tissue-Dependent Efficacy In Vivo. Journal of Pharmacology and Experimental Therapeutics. 290(2). 702–709. 27 indexed citations
5.
Graaf, Piet H. van der, et al.. (1999). Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: prediction of tissue-dependent efficacy in vivo.. PubMed. 290(2). 702–9. 54 indexed citations
6.
Schaick, E.A. van, et al.. (1998). Selectivity of action of 8‐alkylamino analogues of N6‐cyclopentyladenosine in vivo: haemodynamic versus anti‐lipolytic responses in rats. British Journal of Pharmacology. 124(3). 607–618. 35 indexed citations
7.
Schaick, E.A. van, et al.. (1998). Metabolic and Cardiovascular Effects of the Adenosine A1 Receptor Agonist N6-(p-Sulfophenyl)Adenosine in Diabetic Zucker Rats: Influence of the Disease on the Selectivity of Action. Journal of Pharmacology and Experimental Therapeutics. 287(1). 21–30. 11 indexed citations
8.
Schaick, E.A. van, Ron A. A. Mathôt, J. M. Gubbens‐Stibbe, et al.. (1997). 8-Alkylamino-Substituted Analogs of N6-Cyclopentyladenosine Are Partial Agonists for the Cardiovascular Adenosine A1 Receptors in Vivo. Journal of Pharmacology and Experimental Therapeutics. 283(2). 800–808. 19 indexed citations
9.
Schaick, E.A. van, Jacobien K. von Frijtag Drabbe Künzel, Ron A. A. Mathôt, et al.. (1997). Time course of action of three adenosine A1 receptor agonists with differing lipophilicity in rats: comparison of pharmacokinetic, haemodynamic and EEG effects. Naunyn-Schmiedeberg s Archives of Pharmacology. 356(6). 827–837. 10 indexed citations
10.
11.
Schaick, E.A. van, et al.. (1997). Physiological Indirect Effect Modeling of the Antilipolytic Effects of Adenosine A1-Receptor Agonists. Journal of Pharmacokinetics and Biopharmaceutics. 25(6). 673–694. 17 indexed citations
12.
13.
Schaick, E.A. van, Kenneth A. Jacobson, Hea O. Kim, Adriaan P. IJzerman, & Meindert Danhof. (1996). Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-Cl-IB-MECA in conscious rats. European Journal of Pharmacology. 308(3). 311–314. 63 indexed citations
14.
Schaick, E.A. van, et al.. (1996). Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-CL-IB-Meca in concious rats. European Journal of Pharmaceutical Sciences. 4. S79–S79. 1 indexed citations
15.
16.
Mathôt, Ron A. A., E.A. van Schaick, M.W.E. Langemeijer, et al.. (1994). Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat.. Journal of Pharmacology and Experimental Therapeutics. 268(2). 616–624. 45 indexed citations
17.
Mathôt, Ron A. A., Silke Appel, E.A. van Schaick, et al.. (1993). High-performance liquid chromatography of the adenosine A1 agonist N6-cyclopentyladenosine and the A1 antagonist 8-cyclopentyltheophylline and its application in a pharmacokinetic study in rats. Journal of Chromatography B Biomedical Sciences and Applications. 620(1). 113–120. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammad Rafehi Breakdown of academic impact, for papers by Gamini Chandrasena Breakdown of academic impact, for papers by Aliaa Abdelrahman Breakdown of academic impact, for papers by Duncan Armstrong Breakdown of academic impact, for papers by Anthony H. Ingall Breakdown of academic impact, for papers by M. Ohno Breakdown of academic impact, for papers by Markus Muehlbacher Breakdown of academic impact, for papers by Nicola Giacchè Breakdown of academic impact, for papers by Jun Yuan Breakdown of academic impact, for papers by Mark Niosi
Rankless by CCL
2026